Table 2.
Open surgery group (n = 90, 52%) | Laparoscopic group (n = 82, 48%) | P-value | |
---|---|---|---|
Surgical approach, n (%) | |||
Distal | 88 (98) | 81 (99) | 1.0 |
Completion distal | 2 (2) | 1 (1) | 1.0 |
Splenic preservation | 2 (2) | 10 (12) | 0.013 |
Pathology, n (%) | |||
Pancreatic adenocarcinoma | 21 (23) | 18 (22) | 1.0 |
IPMN | 21 (23) | 18 (22) | 1.0 |
PNET | 13 (14) | 13 (16) | 1.0 |
Benign/chronic pancreatitis | 15 (17) | 13 (16) | 1.0 |
Cystic neoplasm | 12 (13) | 14 (17) | 1.0 |
Miscellaneous solid neoplasm | 8 (9) | 6 (7) | 1.0 |
IPMN, intraductal pancreatic mucinous neoplasm; PNET, pancreatic neuroendocrine tumour.